ATE7853T1 - Oberflaechenaktive zusammensetzungen fuer die lunge. - Google Patents

Oberflaechenaktive zusammensetzungen fuer die lunge.

Info

Publication number
ATE7853T1
ATE7853T1 AT81108298T AT81108298T ATE7853T1 AT E7853 T1 ATE7853 T1 AT E7853T1 AT 81108298 T AT81108298 T AT 81108298T AT 81108298 T AT81108298 T AT 81108298T AT E7853 T1 ATE7853 T1 AT E7853T1
Authority
AT
Austria
Prior art keywords
surfactant composition
synthetic
lung
fatty alcohol
surface active
Prior art date
Application number
AT81108298T
Other languages
German (de)
English (en)
Inventor
John Allen Clements
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Application granted granted Critical
Publication of ATE7853T1 publication Critical patent/ATE7853T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
AT81108298T 1980-10-24 1981-10-14 Oberflaechenaktive zusammensetzungen fuer die lunge. ATE7853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/200,216 US4312860A (en) 1980-10-24 1980-10-24 Lung surfactant compositions
EP81108298A EP0050793B1 (en) 1980-10-24 1981-10-14 Lung surfactant compositions

Publications (1)

Publication Number Publication Date
ATE7853T1 true ATE7853T1 (de) 1984-06-15

Family

ID=22740789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81108298T ATE7853T1 (de) 1980-10-24 1981-10-14 Oberflaechenaktive zusammensetzungen fuer die lunge.

Country Status (9)

Country Link
US (1) US4312860A (enExample)
EP (1) EP0050793B1 (enExample)
JP (1) JPS5799524A (enExample)
AT (1) ATE7853T1 (enExample)
BG (1) BG60737B2 (enExample)
CA (1) CA1184503A (enExample)
CS (1) CS384991A3 (enExample)
DE (2) DE3164207D1 (enExample)
NL (1) NL930059I2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US5840527A (en) * 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
EP0223831B1 (en) * 1985-05-22 1992-07-15 Liposome Technology, Inc. Liposome inhalation method and system
US5110806A (en) * 1985-06-26 1992-05-05 The Regents Of The University Of California Lung surfactant compositions
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5207220A (en) * 1989-12-12 1993-05-04 Burroughs Wellcome Co. Method for administering pharmaceuticals, including liquid surfactant, to the lungs
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
US5622715A (en) * 1994-06-10 1997-04-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of improving renal function
US6235308B1 (en) 1994-06-10 2001-05-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating hypertension
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
US5883084A (en) * 1998-06-08 1999-03-16 Clarion Pharmaceuticals Inc. Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
JP2003526437A (ja) * 2000-03-13 2003-09-09 メディ−フィジックス・インコーポレイテッド ガス状過分極１２９Ｘｅの直接注射を使用する診断処置並びに関連するシステムおよび生成物
GB0026239D0 (en) * 2000-10-26 2000-12-13 Britannia Pharmaceuticals Ltd Surface active lipids in treatment of wet lung
AU2005247319B2 (en) * 2004-04-28 2011-12-01 Molecules For Health, Inc. Methods for treating or preventing restenosis and other vascular proliferative disorders
JPWO2005105111A1 (ja) * 2004-04-29 2008-07-31 相男 李 人工肺サーファクタント組成物およびその使用方法
EP2211956A4 (en) 2007-10-10 2014-07-09 Parion Sciences Inc DISPOSAL OF OSMOLYTES WITH A NOSE CANNULA
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
US8778383B2 (en) 2011-06-07 2014-07-15 Parion Sciences, Inc. Methods of treatment
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CA2872029A1 (en) 2012-05-29 2013-12-05 Parion Sciences, Inc. Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
CA2896686A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
PE20151054A1 (es) 2012-12-17 2015-08-07 Parion Sciences Inc Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE388023C (de) * 1922-02-14 1924-01-07 Chem Fab Verfahren zur Herstellung von waesserigen Lezithinemulsionen
US3577446A (en) * 1968-09-09 1971-05-04 American Home Prod Phosphatidylalkanolamine derivatives
DE2629135A1 (de) * 1976-06-29 1978-01-12 Nattermann A & Cie Neue phospholipid-derivate von prostaglandinen und verfahren zu ihrer herstellung
DE2900300A1 (de) * 1979-01-05 1980-07-17 Lebrecht Von Dr Klitzing Verfahren einer prophylaxe zur vermeidung des atemnotsyndroms bei fruehgeborenen und bei der schocklunge

Also Published As

Publication number Publication date
JPH0343252B2 (enExample) 1991-07-01
EP0050793A1 (en) 1982-05-05
BG60737B2 (bg) 1996-01-31
NL930059I2 (nl) 1994-01-03
JPS5799524A (en) 1982-06-21
CS384991A3 (en) 1992-10-14
DE19375071I2 (de) 2006-05-04
CA1184503A (en) 1985-03-26
DE3164207D1 (en) 1984-07-19
US4312860A (en) 1982-01-26
NL930059I1 (nl) 1993-09-01
EP0050793B1 (en) 1984-06-13

Similar Documents

Publication Publication Date Title
DE19375071I2 (de) Oberflächenaktive Zusammensetzungen für die Lunge .
EP0119056A3 (en) Surfactant and pharmaceutical compositions thereof for use in the treatment of respiratory distress syndrome
MX9302843A (es) Composiciones de glicosido de alquilo con propiedades humectantes mejoradas.
NO890226L (no) Organopolysiloxanmasser som kan fornettes til elastomererved avspaltning av alkoholer.
ES2071332T3 (es) Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
DE3883838D1 (de) Transparente Zusammensetzung für Deodorantstifte.
BR8807416A (pt) Processo para preparar uma composicao sulfurada,concentrado de aditivo para uso na preparacao de composicoes lubrificantes e composicao lubrificante
ES8504243A1 (es) Un metodo de fabricar un producto aditivo para detergentes que comprenden un substrato flexible y un precursor de blanq ueo de peroxiacido.
FI853940A0 (fi) Foerfarande foer att berika en blandning av fettsyror med / 6-fettsyror.
SE7903381L (sv) Tandvardsmedel
SE8404930D0 (sv) Aqueous compositions containing stabilized enzymes
ES2107553T3 (es) Composiciones para el cuidado de la piel.
BR8601513A (pt) Processo para a preservacao de bacterias produtoras de acidos,suspensao de bacterias assim preparada e composicao
KR850000961A (ko) 피지분비 촉진제 조성물의 제조방법
FI822733A0 (fi) Fettemulsioner foer parenteral naering
BR9508866A (pt) Composição de gel e de gel Antiperspirante de baixo teor aquoso
KR920011368A (ko) 가공치즈 성분물과 그 이용법
ES8606789A1 (es) Procedimiento para coadyuvar vacunas exentas de aceite.
KR860006982A (ko) 안정한 감마 인터페론 제형의 제조방법
IT1116840B (it) Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina
AR021754A1 (es) Una composicion de acondicionador opaco
SE8203057L (sv) Forbettrat brensle med gasolja som huvudbestandsdel, innefattande vatten och en alkohol
MX9300469A (es) Procedimiento para preparar malato y composicion obtenida con el mismo.
DK0835097T3 (da) Blandede kolloide lipid-hydrogencarbonat-partikler til afgivelse af lægemidler eller kalorier
ATE136328T1 (de) Glycerophospholipidzubereitung mit erhöhter netzmittelwirkung